胺碘酮,Amiodarone
1)Amiodarone胺碘酮
1.Preparation of Molecular Imprinted Polymer Fluorescence Sensing Membrane and Its Application to the Determination ofAmiodarone;一种分子印迹聚合物荧光敏感膜的制备及对胺碘酮含量的测定
2.Severe hepatic injury following intravenous infusion of amiodarone;胺碘酮静脉滴注致严重肝损害
3.Effects and Significance ofAmiodarone on the Proliferation of Human Hepatocellular Carcinoma Cell Line HepG2 in Vitro;胺碘酮对人肝癌HepG2细胞增殖的影响及其临床意义
英文短句/例句
1.Determination of amiodarone and desethylamiodarone in human plasma by HPLCHPLC法测定小剂量胺碘酮及去乙基胺碘酮血药浓度
2.Arrhythmia was finally controlled with amiodarone and digoxin.最后，心律不齐被胺碘酮和地高辛控制。
3.Clinical Observation of Treatment 56 Atrial Fibrillation Patients with Amiodarone;胺碘酮治疗心房纤颤56例临床观察
4.The Effect of Amiodarone on the Senile Patients Suffering From Arrhythmia;胺碘酮治疗老年人心律失常疗效观察
5.Clinical treatment of chronic atrial fibrillation with amiodarone hydrochloride盐酸胺碘酮治疗慢性房颤的临床研究
6.CLINICAL ANALYSIS OF TREATMENT OF ARRHYSTHMIA BY AMIODARONE--REPORT OF 75 CASES胺碘酮治疗心律失常75例临床分析
7.Analysis of 22 Suspected Adverse Reactions of Amiodarone22例胺碘酮疑似不良反应报告分析
8.Current Situation of Application of Amiodarone in Treatment of Arrhythmia胺碘酮在心律失常治疗中的应用现状
parison of the effect of amiodaron on cardioversion of paroxysmal attuak fibrillation胺碘酮转复阵发心房颤动的疗效观察
10.Effect of amiodarone on pharmacokinetics of metoprolol胺碘酮对美托洛尔药代动力学的影响
11.Pharmacokinetics of Amiodarone Dispersible Tablets in Human Plasma人血浆中胺碘酮分散片的药动学研究
parision of Propafenone and Amiodarone in the Treatment and Prevention of Aroxysmal Artial Fribrillation普罗帕酮、胺碘酮治疗与预防阵发性房颤的比较
13.Amiodarone also acts as a thyroid hormone receptor antagonist.胺碘酮也可作为甲状腺激素受体拮抗剂。
14.The Preventive and Therapeutic Effect of Amiodarone on Ischemia-reperfusion Injury in Rat Hearts in Vivo;胺碘酮防治心肌缺血再灌注损伤的实验研究
15.A Systemetic Review and Meta-regression on Amiodarone for Conversion of Atrial Fibrillation to Sinus Rhythm;胺碘酮转复心房颤动的系统评价及meta回归分析
16.The Relationship Study between the Serum Concentration of Amiodarone and QT Dispersion;胺碘酮血药浓度与QT间期离散度的相关性研究
17.Metoprolol Contributed Antiarrhythmic Effect of Amiodarone;美托洛尔对胺碘酮抗心律失常增效作用研究
18.Inhibitory Effects of Amiodarone on Simvastatin Metabolism in Human Microsomes;辛伐他汀与胺碘酮相互作用的体外研究
相关短句/例句
amiodaron胺碘酮
1.Effect of Amiodaron on Malignant Ventricular Arrhythmia;胺碘酮治疗恶性室性心律失常的疗效评价
parison of the effect ofamiodaron on cardioversion of paroxysmal attuak fibrillation胺碘酮转复阵发心房颤动的疗效观察
3.Objective To obsever the efficacy ofamiodarone in patients with malignant ventricular arrhythmia.目的观察胺碘酮治疗器质性心脏病并恶性室性心律失常的近期疗效。
3)amiondarone胺碘酮
1.Analyzing the Effect of Amiondarone on Unstable Angina Pectoris Complicated with Atrial Fibrillation;胺碘酮治疗不稳定型心绞痛并发阵发性心房颤动疗效分析
2.The effect ofamiondarone on treating ventricular arrhythmia in myocardial infarction patients;胺碘酮治疗心肌梗死患者中室性心律失常的疗效观察
3.Conclusion:Amiondarone can not only cure syndrome of Congestive heart failunction and ventricular arrhythmia effectly,but reduce the QTd of the patients,in order to prevent ventricular fibrillation and the happen of sudden cardiac death.目的:观察胺碘酮对充血性心力衰竭合并室性心律失常患者的疗效及QT离散度的影响。
4)amiodarone hydrochloride盐酸胺碘酮
1.Polarographic catalytic wave ofamiodarone hydrochloride in presence of persulphate and its applications;过硫酸钾存在下的盐酸胺碘酮极谱催化波及其应用
patible stability ofamiodarone hydrochloride injection with the three common clinical infusion fluids盐酸胺碘酮注射液与3种临床常用输液的配伍稳定性
3.A HPLC method was established for determination of the related substances inamiodarone hydrochlorideand its dispersible tablets.建立了HPLC法测定盐酸胺碘酮及其分散片的有关物质。
5)Amiodarone乙胺碘肤酮
1.Therapeutic Effects of Buchang Wenxin Granules in combination withAmiodarone for Ventricular Extrasystole;步长稳心颗粒联合乙胺碘肤酮治疗室性早搏临床观察
2.Treatment Effect of Wenxin Grain Combined withAmiodarone for Chronic Atrial Fibrillation;稳心颗粒与乙胺碘肤酮联用治疗慢性房颤的临床研究
3.Clinical Observation ofAmiodarone Used in thePreoperative Preperation in Grave s Disease;乙胺碘肤酮用作甲亢术前准备的临床观察
6)Intravenous miodarone静脉胺碘酮
延伸阅读
胺碘酮分子式：C25H29I2NO3分子量：645.23CAS号：1951-25-3性质：其盐酸盐[19744-82-4]为白色至微带黄白色结晶性粉末。熔点156℃。几乎不溶于水，易溶于氯仿，溶于乙醇，微溶于丙酮。无臭，无味。制备方法：以邻羟基苯甲醛为原料，与1-溴戊酮-2一环合，用水合肼还原，与对甲氧苯甲酰氯缩合，然后水解，碘化，与二乙氨基氯乙烷醚化而得。文献报道的一种醚化操作如下：取135g2-丁基-3（3,5-二碘-4-羟基苯甲酰基）苯并呋喃溶于600ml碳酸乙酯中，以5.7g金属钠制成的甲醇钠的甲醇溶液处理。然后将由51.6gβ-二乙氨基乙基氯盐酸盐于碳酸乙酯中制得的β-二乙氨基乙基氯加入上述钠盐的悬浮液中，混合物加热至温度约90℃并保温约2h，冷却放置过夜，在此期间使氯化钠沉淀完全。含乙胺碘呋喃酮的反应液经纯化、成盐、即得盐酸乙胺碘呋酮。用途：该品为抗心律失常药物。用于各种房性和室性心律失常（包括严重充血性心力衰竭和急性心肌梗塞并发的心律失常）；对服用其他抗心律失常药物无效的病人，服用该品则有明显的效果。该品也可用于冠心病、心绞痛和胸闷的治疗。该品安全范围较其抗心律失常药为大。小鼠静脉注射LD50为160mg/kg，小鼠口服LD50为50g/kg。因此该品以口服治疗时属无毒药物。常见的不良反应有恶心、呕吐、便秘、心动过缓和皮疹等。
